Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen: Aug 2, 2007

Premium
Asuragen has recently introduced the DiscovArray miRNA expression service.
According to the company, the service allows for a comprehensive analysis of miRNA expression profiles from published miRNA sequences and an expanded set of unpublished candidate miRNAs.
 
The platform for the service uses a new Ambion array that is custom-manufactured by Affymetrix and designed specifically for miRNA expression analysis in conjunction with Asuragen’s labeling technology and miRInform web-enabled data-delivery system.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.